Overall rate of minimally invasive surgery declined at a single institution from 2013 to 2015 following the FDA’s recommendations and morcellation guidelines release, although key perioperative outcomes remained similar, a recent study found. The retrospective study reviewed all patients who underwent a hysterectomy for benign indications at Brigham and Women’s Hospital from 2013 to 2015. Rates of abdominal, vaginal, laparoscopic, and robotic-assisted laparoscopic hysterectomy as well as the perioperative outcomes were compared over the study period. Researchers found:
- 1,530 patients underwent a hysterectomy for benign indications and 639 underwent the procedure for the indication of uterine leiomyomas.
- There was a 40% to 60% decreased odds of a minimally invasive procedure in 2014 or 2015 compared with 2013, in patients with leiomyomas alone.
- A 24% decrease in the supracervical approach to hysterectomy was also observed.
- However, the majority of cases in each year were still performed in a minimally invasive fashion.
Ottarsdottir H, Cohen SL, Cox M, Vitonis A, Einarsson JI. Trends in mode of hysterectomy after the U.S. Food and Drug Administration power morcellation advisory. [Published online ahead of print May 5, 2017]. Obstet Gynecol. doi:10.1097/AOG.0000000000002058.
This Week's Must Reads
Must Reads in Gynecology
Management of Early Pregnancy Loss, Obstet Gynecol; ePub 2018 Nov; ACOG
ACOG: Well-Women Visits Can Minimize Health Risks, Obstet Gynecol; 2018 Oct; ACOG, et al